Author

Dinesh Khanna

Professor of Medicine, University of Medicine - Cited by 49,192 - Rheumatology

Biography

Dr Khanna directs a multidisciplinary group of caregivers, scientists, and clinical researchers dedicated to advancing knowledge about scleroderma and related conditions. His research interests include developing new patient-reported outcome measures in patients with scleroderma and different diseases of the joint, and clinical trial design in evaluating new treatments for scleroderma.
Title
Cited by
Year
Therapeutic approaches to systemic sclerosis: recent approvals and future candidate therapies
A Lescoat, D Roofeh, M Kuwana, R Lafyatis, Y Allanore, D KhannaClinical Reviews in Allergy & Immunology 64 (3), 239-261, 2023202
12
2023
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
FF Rahaghi, VM Hsu, RJ Kaner, MD Mayes, IO Rosas, R Saggar, ...Respiratory Research 24 (1), 1-16, 2023202
8
2023
Clinical phenotypes of patients with systemic sclerosis with distinct molecular signatures in skin
M Yang, V Goh, J Lee, M Espinoza, Y Yuan, M Carns, K Aren, L Chung, ...Arthritis Care & Research, 2023202
4
2023
Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort
A Ramahi, A Lescoat, D Roofeh, V Nagaraja, R Namas, S Huang, J Varga, ...Rheumatology 62 (7), 2501-2509, 20220
3
2023
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
A Lescoat, D Huscher, N Schoof, P Airò, J de Vries-Bouwstra, ...Rheumatology 62 (6), 2178-2188, 20220
3
2023
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease
D Roofeh, KK Brown, EA Kazerooni, D Tashkin, S Assassi, F Martinez, ...Rheumatology 6 (5), 1877-1886, 030
2
2023
A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials
RT Domsic, TA Medsger Jr, S Gao, M Laffoon, S Huang, S Wisniewski, ...Rheumatology 6 (4), 1543-1551, 030
2
2023
Systemic sclerosis gastrointestinal dysmotility: Risk factors, pathophysiology, diagnosis and management
ZH McMahan, S Kulkarni, J Chen, JZ Chen, RJ Xavier, PJ Pasricha, ...Nature Reviews Rheumatology 19 (3), 166-181, 030
2
2023
A 24‐Week, Phase IIa, Randomized, Double‐blind, Placebo‐controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis (NOVESA)
A 4‐Week, Phase IIa, Randomized, Double‐blind, Placebo‐controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis (NOVESA)D Khanna, CP Denton, DE Furst, MD Mayes, M Matucci‐Cerinic, V Smith, ...Arthritis & Rheumatology, 030
2
2023
‘I turned in my man card’: a qualitative study of the experiences, coping styles and support needs of men with systemic sclerosis
CA Flurey, JD Pauling, LA Saketkoo, CP Denton, P Galdas, D Khanna, ...Rheumatology 62 (6), 260-267, 2023202
1
2023
Scleroderma
JO Clarke, FP Tripp Buckley III, Z McMahan, D KhannaThe AFS Textbook of Foregut Disease, 357-366, 2023202
1
2023
Gene expression signatures in inflammatory and sclerotic morphea skin and sera distinguish morphea from systemic sclerosis
HW Chen, JL Zhu, V Martyanov, LC Tsoi, ME Johnson, G Barber, ...Journal of Investigative Dermatology, 2023202
1
2023
Senescent cells accumulate in systemic sclerosis skin
B Shi, PS Tsou, F Ma, MP Mariani, MN Mattichak, NK LeBrasseur, ...The Journal of investigative dermatology 43 (4), 66, 2023202
1
2023
Three distinct transcriptional profiles of monocytes associate with disease activity in scleroderma patients
HKM Makinde, JLM Dunn, G Gadhvi, M Carns, K Aren, AH Chung, ...Arthritis & rheumatology 75 (4), 595-608, 20231202
1
2023
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
D Khanna, TM Maher, ER Volkmann, Y Allanore, V Smith, S Assassi, ...RMD open 9 (), e002859, 2023202
1
2023